Leaflet ROXIPER 20mg / 4mg / 1.25mg film-coated tablets

Indicated for: dyslipidemia

Route of administration: oral

Substance: rosuvastatin + perindopril + indapamide (statin lipid-lowering agent + ACE inhibitor + diuretic)

ATC: C10BX13 (Cardiovascular system | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hepatotoxicity
Hepatotoxicity

This medicine may affect the liver.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Myopathy / rhabdomyolysis
Myopathy / rhabdomyolysis

Seek medical advice if unexplained muscle pain occurs.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

Rosuvastatin+perindopril+indapamide is a combination medication used for the treatment of dyslipidemia, hypertension, and the prevention of cardiovascular diseases. Rosuvastatin lowers LDL cholesterol and triglycerides, perindopril is an angiotensin-converting enzyme (ACE) inhibitor that reduces blood pressure, and indapamide is a thiazide diuretic that helps eliminate excess fluids and lower blood pressure.

This combination is taken orally, usually once daily, and is indicated for patients at high cardiovascular risk, including those with hypertension and associated dyslipidemia. It is commonly used to reduce the risk of major cardiovascular events such as myocardial infarction and stroke.

Common side effects include dizziness, nausea, muscle pain, and fatigue. In rare cases, severe adverse reactions such as kidney failure, hyperkalemia, or rhabdomyolysis may occur. Regular monitoring of renal function, blood pressure, and lipid profile is essential.

Rosuvastatin+perindopril+indapamide is a comprehensive therapeutic option for patients with multiple cardiovascular risk factors, offering significant benefits in a single administration.

General data about ROXIPER 20mg / 4mg / 1.25mg

  • Substance: rosuvastatin + perindopril + indapamide
  • Date of latest medicines list: 01-06-2026
  • Product code: W65528003
  • Concentration: 20mg / 4mg / 1.25mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 30
  • Product type: Generic medicine
  • Price: 44.38 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: KRKA D.D., NOVO MESTO - SLOVENIA
  • Holder: KRKA D.D., NOVO MESTO - SLOVENIA
  • Number: 11166/2018/03
  • Shelf life: 2 years

Concentrations available for rosuvastatin + perindopril + indapamide

  • 10mg/4mg/1.25mg
  • 10mg/8mg/2.5mg
  • 20mg/4mg/1.25mg
  • 20mg/8mg/2.5mg

Compensation lists for ROXIPER 20mg / 4mg / 1.25mg KRKA

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

44.38 RON

22.19 RON

22.19 RON